Comparison of cold biopsy forceps vs cold snare for diminutive colorectal polyp removal: A multicenter non-inferiority randomized controlled trial

医学 息肉切除术 结肠镜检查 随机化 镊子 粘膜切除术 随机对照试验 外科 活检 不利影响 临床终点 结直肠癌 胃肠病学 内科学 切除术 癌症
作者
Guillaume Perrod,Enrique Pérez‐Cuadrado‐Robles,Emmanuel Coron,Mathieu Pioche,Aymeric Becq,Nicolas Etchepare,David Danan,Nicolas Musquer,Xavier Dray,A. Laquière,Bénédicte Jaïs,Chloé Broudin,Hédi Benosman,Christophe Cellier,Gabriel Rahmi
出处
期刊:Clinics and Research in Hepatology and Gastroenterology [Elsevier]
卷期号:46 (3): 101867-101867 被引量:6
标识
DOI:10.1016/j.clinre.2022.101867
摘要

European guidelines recommends the use of cold snare polypectomy (CSP) for removal of diminutive colorectal polyps (DCP). However, for DCP < 4 mm cold biopsy forceps (CBF) may be optional. We aimed to compare the efficacy of CSP with CBF for removal of DCP in routine colonoscopy.We conducted a multicenter non-inferiority randomized controlled trial. After screening, 123 patients were prospectively included and 180 DCPs were removed by either CBF or CSP after randomization (1:1). The primary end-point was the histological complete resection rate defined by negative additional biopsies taken from the edge of the polypectomy ulcer site.Among DCPs, 121 (67.2%) adenomas or sessile serrated lesions were considered for the analysis. Polyps were 4 [1-5] mm in size, mostly flat (55.4%) and located in the proximal colon (44.6%). The en bloc resection rate was higher in the CSP group than the CBF group (91.7% vs. 42.6%, p < 0.001). The histological complete resection rate was comparable in the two groups (93.33% vs 90.16%; p = 0.527), even for polyps < 4 mm (91.30% vs 91.30%; p = 1). All specimens were retrieved and there was no difference in terms of procedure times and adverse events. Finally, univariate analysis did not identify any potential factor associated with complete resection rate.In this study, CSP was comparable to CBF for the removal of DCP. Therefore, CBF may be considered as an alternative technique for resection of DCP, together with CSP, ClinicalTrials.gov registry (NCT04727918).

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
innyjiang完成签到,获得积分10
1秒前
jixueyan发布了新的文献求助10
1秒前
愤怒的狗发布了新的文献求助10
3秒前
大不了XX发布了新的文献求助10
3秒前
water_marvel完成签到,获得积分20
4秒前
bkagyin应助有魅力的音响采纳,获得10
6秒前
一xiaoxiao完成签到,获得积分20
7秒前
7秒前
努力向上的曼关注了科研通微信公众号
7秒前
Cc关闭了Cc文献求助
7秒前
wangdada完成签到,获得积分10
7秒前
科研通AI6.3应助kk采纳,获得10
9秒前
niuniu完成签到,获得积分10
10秒前
乐乐发布了新的文献求助80
11秒前
淡定的一德完成签到,获得积分10
12秒前
tt完成签到,获得积分10
13秒前
刘文辉完成签到,获得积分10
14秒前
rs完成签到,获得积分10
14秒前
sansronds完成签到,获得积分10
15秒前
16秒前
jixueyan完成签到,获得积分20
16秒前
17秒前
自由一一发布了新的文献求助10
17秒前
bkagyin应助还单身的含烟采纳,获得10
18秒前
966发布了新的文献求助10
18秒前
香蕉觅云应助lin采纳,获得10
19秒前
可爱的函函应助lin采纳,获得10
19秒前
NexusExplorer应助lin采纳,获得10
19秒前
王伟轩应助jjready采纳,获得10
19秒前
隐形曼青应助lin采纳,获得10
19秒前
科研通AI6.1应助lin采纳,获得10
19秒前
19秒前
黄油小xin完成签到 ,获得积分10
21秒前
niuniuuuu完成签到,获得积分10
22秒前
Kimberlyn完成签到 ,获得积分10
22秒前
长安完成签到 ,获得积分10
23秒前
赘婿应助ai化学采纳,获得10
24秒前
赘婿应助苍术采纳,获得10
24秒前
1234567发布了新的文献求助10
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
VASCULITIS(血管炎)Rheumatic Disease Clinics (Clinics Review Articles) —— 《风湿病临床》(临床综述文章) 1000
Feldspar inclusion dating of ceramics and burnt stones 1000
What is the Future of Psychotherapy in a Digital Age? 801
The Psychological Quest for Meaning 800
Digital and Social Media Marketing 600
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5977450
求助须知:如何正确求助?哪些是违规求助? 7338065
关于积分的说明 16010164
捐赠科研通 5116845
什么是DOI,文献DOI怎么找? 2746683
邀请新用户注册赠送积分活动 1715088
关于科研通互助平台的介绍 1623852